Korro Bio, Inc. beat EPS estimates 50% of the time across 2 reported quarters (1 beats, 1 misses), averaging +12.4% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $-1.54 | $-1.07 | +30.5% | Beat | |
| Q1 FY26 | $-1.60 | $-1.69 | -5.6% | Miss | |
| Q4 FY25 | not reported | $-5.32 | not reported | not reported |
Back to KRRO overview · KRRO holders · KRRO KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.